Detailed Information on Publication Record
2019
Analysis and management of drug related problems on a nephrology ward from a pharmacist's point of view
DVORACKOVA, E., Jitka RYCHLÍČKOVÁ, P. PAVEK, M. HOJNY, J. VLCEK et. al.Basic information
Original name
Analysis and management of drug related problems on a nephrology ward from a pharmacist's point of view
Authors
DVORACKOVA, E. (203 Czech Republic, guarantor), Jitka RYCHLÍČKOVÁ (203 Czech Republic, belonging to the institution), P. PAVEK (203 Czech Republic), M. HOJNY (203 Czech Republic) and J. VLCEK (203 Czech Republic)
Edition
Pharmazie, ESCHBORN, GOVI-VERLAG PHARMAZEUTISCHER VERLAG GMBH, 2019, 0031-7144
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.198
RIV identification code
RIV/00216224:14110/19:00113857
Organization unit
Faculty of Medicine
UT WoS
000525868800011
Keywords in English
CHRONIC KIDNEY-DISEASE; CLINICAL PHARMACISTS; OUTCOMES; CARE; INTERVENTIONS; MEDICATIONS; PREVALENCE; GUIDELINE; SERVICES; IMPACT
Tags
International impact, Reviewed
Změněno: 5/5/2020 10:10, Mgr. Tereza Miškechová
Abstract
V originále
The main goal of the study was to determine the incidence and the character of drug related problems (DRPs) identified in chronic kidney disease patients by the clinical pharmacist at the nephrology department. As secondary objective, the aim was to identify the frequency and character of DRPs of selected high risk drugs in medication reviews. The clinical pharmacist reviewed patients. medication records and made drug therapy-related recommendations to physicians. The clinical pharmacists. interventions were categorized using an adaptation of the Pharmaceutical Care Network Europe. During the study period (January 2016 - June 2018) the clinical pharmacist performed 1192 interventions in 1870 adult patients admitted to the Nephrology Department. The most frequent DRP was untreated indication 324 (27.18%) of all interventions, and incorrect dose 248 (20.81%). Anti-infectives were identified as the drug category with the highest frequency of interventions. Almost 93% of all interventions were accepted by the attending physicians. Still within the second objectives, underdosing was observed as the most frequent problem for renally excreted drugs. It was found that an incorrect dose is a very frequent issue at the nephrology department. Surprisingly, the main problem was underdosing. In the category of renally excreted drugs, underdosing was observed in antithrombotics and antivirals. The above- mentioned results prove the need of a clinical pharmacist, preferably in sense of maximizing of the treatment effect and improving the care of patients.